Latest Insider Transactions at Adaptive Biotechnologies Corp (ADPT)
This section provides a real-time view of insider transactions for Adaptive Biotechnologies Corp (ADPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adaptive Biotechnologies Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adaptive Biotechnologies Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 25
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 22
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-68.41%
|
$990,000
$66.71 P/Share
|
|
Jan 22
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 21
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
23,370
-59.38%
|
$1,542,420
$66.85 P/Share
|
|
Jan 21
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,370
+49.28%
|
$140,220
$6.32 P/Share
|
|
Jan 21
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-80.81%
|
$990,000
$66.88 P/Share
|
|
Jan 21
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 20
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-63.33%
|
$3,350,000
$67.5 P/Share
|
|
Jan 20
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 20
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-56.4%
|
$1,005,000
$67.47 P/Share
|
|
Jan 20
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-69.96%
|
$3,350,000
$67.48 P/Share
|
|
Jan 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.66%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
25,000
-71.43%
|
$1,725,000
$69.0 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Exercise of conversion of derivative security
|
Direct |
23,000
-39.66%
|
$92,000
$4.07 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.29%
|
$0
$0.84 P/Share
|
|
Jan 19
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-68.18%
|
$1,050,000
$70.0 P/Share
|
|
Jan 19
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 19
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-52.24%
|
$3,400,000
$68.95 P/Share
|
|
Jan 19
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.66%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-44.64%
|
$3,400,000
$68.82 P/Share
|
|
Jan 19
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
8,400
-0.24%
|
$588,000
$70.78 P/Share
|
|
Jan 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
417
-100.0%
|
$28,773
$69.0 P/Share
|
|
Jan 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+50.0%
|
$2,502
$6.27 P/Share
|
|
Jan 15
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-72.25%
|
$132,000
$66.51 P/Share
|
|
Jan 15
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Jan 15
2021
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-84.45%
|
$132,000
$66.7 P/Share
|
|
Jan 15
2021
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Jan 15
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-72.3%
|
$990,000
$66.38 P/Share
|
|
Jan 15
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-92.01%
|
$396,000
$66.1 P/Share
|
|
Jan 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$42,000
$7.8 P/Share
|
|
Jan 14
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-91.8%
|
$975,000
$65.92 P/Share
|
|
Jan 14
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 13
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-64.09%
|
$3,150,000
$63.28 P/Share
|
|
Jan 13
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 13
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-77.05%
|
$945,000
$63.26 P/Share
|
|
Jan 13
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 12
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,000
-67.01%
|
$4,650,000
$62.98 P/Share
|
|
Jan 12
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+49.67%
|
$450,000
$6.32 P/Share
|
|
Jan 12
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-82.91%
|
$930,000
$62.79 P/Share
|
|
Jan 12
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 11
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-46.23%
|
$900,000
$60.68 P/Share
|
|
Jan 11
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
8,814
-42.54%
|
$520,026
$59.96 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
BUY
Open market or private sale
|
Direct |
6,186
+55.58%
|
$371,160
$60.44 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 07
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$855,000
$57.3 P/Share
|
|
Jan 07
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|